Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,558,034
-
Share change
-
-565,730
-
Total reported value
-
$268,031,443
-
Price per share
-
$16.26
-
Number of holders
-
65
-
Value change
-
-$10,328,094
-
Number of buys
-
40
-
Number of sells
-
19
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q2 2019
As of 30 Jun 2019,
AVROBIO INC - COM (AVRO) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,558,034 shares.
The largest 10 holders included
SV Health Investors, LLC, CITADEL ADVISORS LLC, Blackstone Group Inc, JPMORGAN CHASE & CO, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, Aisling Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, and VANGUARD GROUP INC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.